urmjУральский медицинский журналUral Medical Journal2949-4389Ural State Medical University10.25694/URMJ.2018.09.19urmj-299Research ArticleОНКОУРОЛОГИЯМесто сальважной радикальной простатэктомии, криоаблации и HIFU-аблации в ведении пациентов с рецидивом рака простаты после лучевой терапииRole of salvage radical prostatectomy, cryoablation and HIFU-ablation in management of patients with prostate cancer recurrence after radiation therapyФомкинРоман НиколаевичFomkinR. N.rnfomkin@ mail.ruШатылкоТарас ВалерьевичShatylkoT. V.noemail@neicon.ruФГБОУ ВО „Саратовский государственный медицинский университет имени В. И. Разумовского“ Минздрава РоссииRussian Federation20181404202109107111Copyright © Фомкин Р.Н., Шатылко Т.В., 20212021Фомкин Р.Н., Шатылко Т.В.Fomkin R.N., Shatylko T.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.umjusmu.ru/jour/article/view/299

Существует несколько вариантов сальважного лечения при рецидивах рака простаты после лучевой терапии. Основным вариантом является сальважная радикальная простатэктомия, которая обеспечивает оптимальный онкологический контроль и даёт возможность гистологического стадирования, но является технически трудной и грозит рядом осложнений. Альтернативными вариантами сальважной терапии являются HIFU-аблация и криоаблация. В обзоре представлена роль каждого из этих методов, их онкологическая эффективность и частота развития осложнений.

Several options for salvage treatment of radiation-recurrent prostate cancer exist. The main option is a salvage radical prostatectomy, which offers optimal cancer control and allows to perform specimen pathology, but it is technically challenging and poses increased risk for certain complications. Alternative modalities of salvage therapy are HIFU-ablation and cryoablation. This review covers the role for those methods, their oncological efficacy and morbidity.

сальважная терапиясальважная радикальная простатэктомияHIFU-аблациякриоаблациярак простатыsalvage therapysalvage radical prostatectomyHIFU-ablationcryoablationprostate cancerReferencesBianco FJ. Jr., Scardino P.T., Stephenson A.J., Diblasio C.J., Fearn P.A., Eastham J.A. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2005; 62: 448-453.Bianco FJ. Jr., Scardino P.T., Stephenson A.J., Diblasio C.J., Fearn P.A., Eastham J.A. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2005; 62: 448-453.Ward J.F., Sebo T.J., Blute M.L., Zincke H. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol. 2005; 173:1156-1160.Ward J.F., Sebo T.J., Blute M.L., Zincke H. Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol. 2005; 173:1156-1160.Amling C.L., Lerner S.E., Martin S.K., Slezak J.M., Blute M.L., Zincke H. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol. 1999; 161: 857-862.Amling C.L., Lerner S.E., Martin S.K., Slezak J.M., Blute M.L., Zincke H. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol. 1999; 161: 857-862.Cheng L., Sebo T.J., Slezak J., Pisansky T.M., Bergstralh E.J., Neumann R.M. et al. Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer. 1998; 83: 2164-2171.Cheng L., Sebo T.J., Slezak J., Pisansky T.M., Bergstralh E.J., Neumann R.M. et al. Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy. Cancer. 1998; 83: 2164-2171.Gheiler E.L., Tefilli M.V., Tiguert R., Grignon D., Cher M.L., Sakr W. et al. Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology. 1998; 51: 789-795.Gheiler E.L., Tefilli M.V., Tiguert R., Grignon D., Cher M.L., Sakr W. et al. Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology. 1998; 51: 789-795.Rogers E., Ohori M., Kassabian VS., Wheeler T.M., Scardino P. T. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol. 1995; 153: 104-110.Rogers E., Ohori M., Kassabian VS., Wheeler T.M., Scardino P. T. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol. 1995; 153: 104-110.Boris R.S., Bhandari A., Krane L.S., Eun D., Kaul S., Peabody J.O. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes. BJU Int. 2009; 103: 952-956.Boris R.S., Bhandari A., Krane L.S., Eun D., Kaul S., Peabody J.O. Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes. BJU Int. 2009; 103: 952-956.Kaouk J.H., Hafron J., Goel R., Haber G.P., Jones J.S. Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results. BJU Int. 2008; 102: 93-96.Kaouk J.H., Hafron J., Goel R., Haber G.P., Jones J.S. Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results. BJU Int. 2008; 102: 93-96.Leibovici D., Spiess P.E., Heller L., Rodriguez-Bigas M., Chang G., Pisters L.L. Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol. 2008; 26: 9-16.Leibovici D., Spiess P.E., Heller L., Rodriguez-Bigas M., Chang G., Pisters L.L. Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol. 2008; 26: 9-16.Monti P.R., Lara R.C., Dutra M.A., De Carvalho J.R. New techniques for construction of efferent conduits based on the Mitrofanoff principle. Urology. 1997; 49: 112-115.Monti P.R., Lara R.C., Dutra M.A., De Carvalho J.R. New techniques for construction of efferent conduits based on the Mitrofanoff principle. Urology. 1997; 49: 112-115.Touma N.J., Izawa J.I., Chin J.L. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol. 2005; 173: 373-379.Touma N.J., Izawa J.I., Chin J.L. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol. 2005; 173: 373-379.Stephenson A.J., Scardino P.T., BiancoF.J. Jr., DiBlasio C.J., Fearn P.A., Eastham J.A. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol. 2004; 172: 2239-2243.Stephenson A.J., Scardino P.T., BiancoF.J. Jr., DiBlasio C.J., Fearn P.A., Eastham J.A. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol. 2004; 172: 2239-2243.Masterson T.A., Stephenson A.J., Scardino P. T., Eastham J.A. Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology. 2005; 66: 623-626.Masterson T.A., Stephenson A.J., Scardino P. T., Eastham J.A. Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology. 2005; 66: 623-626.Sylvester J., Grimm P., Blasco J., Meier R., Spiegel J., Heaney C. et al. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States. Urology. 2001; 58: 65-70.Sylvester J., Grimm P., Blasco J., Meier R., Spiegel J., Heaney C. et al. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States. Urology. 2001; 58: 65-70.Chin J.L., Pautler S.E., Mouraviev V., Touma N., Moore K., Downey D.B. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol. 2001; 165: 1937-1941.Chin J.L., Pautler S.E., Mouraviev V., Touma N., Moore K., Downey D.B. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol. 2001; 165: 1937-1941.Izawa J.I., Madsen L.T., Scott S.M., Tran J.P., McGuire E.J., Von Eschenbach A.C. et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol. 2002; 20: 2664-2671.Izawa J.I., Madsen L.T., Scott S.M., Tran J.P., McGuire E.J., Von Eschenbach A.C. et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol. 2002; 20: 2664-2671.Ng C.K., Moussa M., Downey D.B., Chin J.L. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. J Urol. 2007; 178: 1253-1257.Ng C.K., Moussa M., Downey D.B., Chin J.L. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. J Urol. 2007; 178: 1253-1257.Cresswell J., Asterling S., Chaudhary M., Sheikh N., Greene D. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int. 2006; 97: 969-974.Cresswell J., Asterling S., Chaudhary M., Sheikh N., Greene D. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int. 2006; 97: 969-974.Ismail M., Ahmed S., Kastner C., Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007; 100: 760-764.Ismail M., Ahmed S., Kastner C., Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007; 100: 760-764.Pisters L.L., Rewcastle J.C., Donnelly B.J., Lugnani F.M., Katz A.E., Jones J.S. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008; 180: 559-563.Pisters L.L., Rewcastle J.C., Donnelly B.J., Lugnani F.M., Katz A.E., Jones J.S. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008; 180: 559-563.Eisenberg M.L., Shinohara K. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology. 2008; 72: 1315-1318.Eisenberg M.L., Shinohara K. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology. 2008; 72: 1315-1318.Pisters L.L., Von Eschenbach A.C., Scott S.M., Swanson D.A., Dinney C.P., Pettaway C.A. et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997; 157: 921-925.Pisters L.L., Von Eschenbach A.C., Scott S.M., Swanson D.A., Dinney C.P., Pettaway C.A. et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997; 157: 921-925.Ghafar M.A., Johnson C.W., De La Taille A., Benson M.C., Bagiella E., Fatal M. et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol. 2001; 166: 1333-1337.Ghafar M.A., Johnson C.W., De La Taille A., Benson M.C., Bagiella E., Fatal M. et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol. 2001; 166: 1333-1337.Nguyen P.L., D’Amico A.V., Lee A.K., Suh W. W. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer. 2007; 110: 1417-1428.Nguyen P.L., D’Amico A.V., Lee A.K., Suh W. W. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer. 2007; 110: 1417-1428.Ahmed S., Lindsey B., Davies J. Salvage cryosurgery for locally recurrent prostate cancer following radiotherapy. Prostate Cancer Prostatic Dis. 2005; 8: 31-35.Ahmed S., Lindsey B., Davies J. Salvage cryosurgery for locally recurrent prostate cancer following radiotherapy. Prostate Cancer Prostatic Dis. 2005; 8: 31-35.Cohen J.K. Cryosurgery of the prostate: techniques and indications. Rev Urol. 2004; 6 (Suppl. 4): S20-26.Cohen J.K. Cryosurgery of the prostate: techniques and indications. Rev Urol. 2004; 6 (Suppl. 4): S20-26.Попков В.М., Фомкин Р.Н., Блюмберг Б.И., Шатылко Т.В., Седова Л.Н., Абрамова Э.П. Комбинирование трансуретральной резекции и HIFU-аблации простаты при лечении локализованного рака. Саратовский научно-медицинский журнал. 2014. 10 (3):450-455.Попков В.М., Фомкин Р.Н., Блюмберг Б.И., Шатылко Т.В., Седова Л.Н., Абрамова Э.П. Комбинирование трансуретральной резекции и HIFU-аблации простаты при лечении локализованного рака. Саратовский научно-медицинский журнал. 2014. 10 (3):450-455.Zacharakis E., Ahmed H.U., Ishaq A., Scott R., Illing R., Freeman A. et al. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int. 2008; 102: 786-792.Zacharakis E., Ahmed H.U., Ishaq A., Scott R., Illing R., Freeman A. et al. The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy. BJU Int. 2008; 102: 786-792.Chalasani V., Martinez C.H., Lim D., Chin J. Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis. 2009; 12: 124-129.Chalasani V., Martinez C.H., Lim D., Chin J. Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer Prostatic Dis. 2009; 12: 124-129.Murat F.J., Poissonnier L., Rabilloud M., Belot A., Bouvier R., Rouviere O. et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol. 2008; 55: 640-649.Murat F.J., Poissonnier L., Rabilloud M., Belot A., Bouvier R., Rouviere O. et al. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol. 2008; 55: 640-649.Gelet A., Chapelon J.Y., Poissonnier L., Bouvier R., Rouvière O., Curiel L. et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology. 2004; 63: 625-629.Gelet A., Chapelon J.Y., Poissonnier L., Bouvier R., Rouvière O., Curiel L. et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology. 2004; 63: 625-629.Фомкин Р.Н., Шатылко Т.В. Надир ПСА как основной предиктор рецидива локализованного рака простаты после HIFU-аблации. Новости хирургии. 2016; 24 (5): 489-496.Фомкин Р.Н., Шатылко Т.В. Надир ПСА как основной предиктор рецидива локализованного рака простаты после HIFU-аблации. Новости хирургии. 2016; 24 (5): 489-496.Фомкин Р.Н., Попков В.М., Шатылко Т.В. Факторы, предиктивные в отношении формирования инфравезикальной обструкции после HIFU-аблации по поводу локализованного рака простаты. Медицинский альманах. 2015; 2 (37): 68-71.Фомкин Р.Н., Попков В.М., Шатылко Т.В. Факторы, предиктивные в отношении формирования инфравезикальной обструкции после HIFU-аблации по поводу локализованного рака простаты. Медицинский альманах. 2015; 2 (37): 68-71.Безруков Е.А., Лачинов Э.Л., Мартиросян Г.А. Факторы местного рецидива после радикальной простатэктомии. Медицинский вестник Башкортостана. 2015; 10 (3): 203-205.Безруков Е.А., Лачинов Э.Л., Мартиросян Г.А. Факторы местного рецидива после радикальной простатэктомии. Медицинский вестник Башкортостана. 2015; 10 (3): 203-205.

The authors declare that there are no conflicts of interest present.